IP Library › Granted Patent US 11,744,732
Granted Patent B2
US 11,744,732 · App. 15/788,676 · Granted Sep 5, 2023

Medication-coated patient interface device for ophthalmic laser surgery

Inventors: Jose L. Garcia (Fremont, CA); Vye Chi Low (Milpitas, CA); Audrey Jonas (Palo Alto, CA)
Assignee: AMO Development, LLC
A61F9/0026A61F9/00754B29C45/0053B29C45/263A61F9/009B29C2045/0079B29K2083/00B29K2101/12B29L2031/7546
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,744,732
App. No.
15/788,676
Granted
Sep 5, 2023
Kind
B2
Abstract

A patient interface device for use in ophthalmic surgery, which includes a rigid body and a suction ring joined to a lower end of the body, where the suction ring includes an annular skirt made of a soft and flexible material and located at a lower end of the suction ring, and where an inner surface, and optionally an outer surface, of the skirt is coated with medication. The medication includes one or more of the following types of medication: anti-inflammatory, antibiotic, numbing, lubricating, and anti-redness. The coating method may include dip coating, sputter deposition, ultrasonic-spraying, and spin-coating. The skirt may be formed by a process that increases its material porosity and/or surface roughness, and may be surface-treated to enhance adhesion and retention of the medication.

Claims (19)

1. A patient interface device for use in ophthalmic surgery, comprising:

a rigid body; and

a suction ring joined to a lower end of the body,

wherein the suction ring includes an annular skirt made of a soft and flexible thermoplastic elastomer (TPE) material and located at a lower end of the suction ring, wherein the TPE material has a texturized surface with a surface roughness value between 0.8 m to 25 um, and

wherein an inner surface of the annular skirt is coated with a first medication and an outer surface of the annular skirt is coated with a second medication.

2. The patient interface device of claim 1 , wherein the first or second medication includes one or more of: anti-inflammatory medication, antibiotic medication, numbing medication, lubricating medication, and anti-redness medication.

3. The patient interface device of claim 1 , wherein the second medication coated on the outer surface and the first medication coated on the inner surface of the annular skirt are different medications.

4. The patient interface device of claim 1 , wherein the TPE material has a porosity of about 12-30%.

5. The patient interface device of claim 1 , wherein the annular skirt is made of a plasma-treated thermoplastic elastomer (TPE) material.

6. A method for forming a patient interface device for use in ophthalmic surgery, comprising:

forming a rigid body and a suction ring joined to a lower end of the body,

wherein the suction ring includes an annular skirt made of a soft and flexible thermoplastic elastomer (TPE) material and located at a lower end of the suction ring, including forming the annular skirt by injection molding using a texturized mold, wherein the annular skirt has a surface roughness value between 0.8 um to 25 um; and

coating an inner surface of the annular skirt with a first medication and an outer surface of the annular skirt with a second medication.

7. The method of claim 6 , wherein the coating step includes one of: dip coating, sputter deposition, ultrasonic-spraying, and spin-coating.

8. The method of claim 6 , further comprising, before the coating step: prepping the inner surface of the skirt to increase adhesion and retention of the medication.

9. The method of claim 6 , wherein the first or second medication includes one or more of: anti-inflammatory medication, antibiotic medication, numbing medication, lubricating medication, and anti-redness medication.

10. The method of claim 6 , wherein the second medication coated on the outer surface and the first medication coated on the inner surface of the annular skirt are different medications.

11. The method of claim 6 , wherein the TPE material has a porosity of about 12-30%.

12. The method of claim 6 , further comprising: prior to coating, plasma-treating the annular skirt.

Continuity (1)
Related Publication 20190117455A1 · Apr 25, 2019